#molson marijuana

[planesspoken]

Anti-Marijuana Guy Pitches “Bob Marley and the Flailers” until nobody makes Holy Spirit

Marley on Trial, Bio Pic in the works.

Bio Pic not great, not helping matters.

PSA’s made to get out of jail.

Not many buying the PSA’s but it’s so damn loud says one.

Plus look at this guy, he could be more efficient.

It’s business another, biometrics multilevel buy in.

Is it a family business? Then what are we talking about.

Smell a spice rack, not a skunk.

Ah Molson.

It’s a fantasy.

It’s spice and span.

This is getting old.

Cue the under arm commercial.

[thesuntrapp]

How Many Calories In Miller Lite Beer?

If you're looking to cut back on calories, but still want a refreshing drink, then Miller Lite may be the right choice for you. It has a low calorie count and a low carbohydrate content, making it ideal for those on a diet or weight loss plan.

It's made from water, barley malt, corn syrup and hops extract. It's a classic American pilsner beer with all the crisp flavor you love without the extra sugar and calories.

Introduction

The number one question people ask about Miller Lite beer is, "How many calories in miller lite?" This light American beer is known for its refreshing flavor and low-calorie content.

This pilsner-style beer has 4.2% ABV and is brewed with water, barley malt, and hops to give it its crisp, light taste. It is also a good source of Vitamin B6, Vitamin C, Vitamin B12, and potassium.

Its low calorie content makes it a favorite among those who want to drink beer but need to watch their weight or diet in some way. A 12-ounce serving of Miller Lite contains 96 calories, which is significantly less than other popular light beers like Bud Light and Coors Light.

However, it is still important to remember that calories can add up quickly and moderation is key. Moreover, it is a good idea to exercise regularly to help burn off the calories in your beer.

Although there are a few other options on the market, Miller Lite is one of the best light beers out there. Its low calorie and carbohydrate content make it an ideal choice for anyone who wants to enjoy their beer while watching their health.

What Is Miller Lite Beer?

There are many different types of beer, but Miller Lite is one of the most popular in America. It is a 4.2% ABV light American lager beer made by Molson Coors.

It is brewed with a 21-day brewing process, including Galena hops, specially grown barley, and water that is purified. This makes the beer taste clean and refreshing.

The beer is also a great choice for those who want to lower their carbohydrate intake and calories. It is a low-calorie alternative to other beers, such as Bud Light or Coors Light.

This beer is categorized as an American Light Lager by the Beer Judge Certification Program. It has a low bitterness (IBU of 12), a light corn-like color (SRM of 2-3) and a 4.2% ABV.

During its history, Miller Lite has fought off competition from other alcoholic beverages like beer sodas and other carbonated drinks. But now, it’s facing another threat: cannabis.

In the fight for consumer dollars, Miller Lite and its competitors may be facing bigger problems than they realize. With recreational marijuana legal in 18 states, it’s not hard to imagine the beer industry losing its dominance.

The Ingredients Of Miller Lite Beer?

To make a good beer, you need to use a combination of ingredients. These include water, barley malt that can be fermented to produce alcohol, brewer's yeast, and hops for flavor.

Miller Lite is a pilsner-style American light lager, meaning that it is lower in alcohol than most other beers on the market. This makes it a perfect drink for people who are trying to stick to a diet.

The beer is made with water, barley malt, corn syrup (dextrose), brewer's yeast, and hops. The hops are used to balance the malt flavor, so that it remains smooth and crisp.

This type of beer is brewed with fresh water from deep lakes and ancient aquifers, which minimizes the amount of impurities in the brew. This helps to create a smooth, refreshing taste that you can enjoy any time of the day.

The beer also contains no high fructose corn syrup, which is a popular sweetener used by many other companies. This is because it has been linked to several health problems in the past.

The Ingredients Of Miller Lite Beer?

How Many Calories Are There In A Can Of Miller Lit?

Miller Lite Beer is one of the most popular light beers on the market. It contains fewer calories and carbohydrates than regular beers, making it a great choice for anyone looking to cut back on their calorie intake.

It also offers a low-sugar and low-salt content, which makes it a great option for those with diabetes or high blood pressure. It is also gluten-free, which makes it an excellent choice for those with celiac disease or gluten sensitivity.

While the calorie count in Miller Lite is relatively low, it is not considered the healthiest beer on the market. This is because it does not have a high amount of antioxidants and it may contain other ingredients that are not considered healthy for you.

Another thing to consider is the amount of corn syrup in this beer. While it is used as part of the brewing process, Miller Lite never uses corn syrup as a main source of sugar. This is important because corn syrup can be unhealthy and it has been linked to obesity.

How Many Calories Are There In A Can Of Miller Lit?

How Many Calories Are There In A 12 Oz Miller Lite

If you are looking for a low calorie beer, Miller Lite is a great choice. It contains 96 calories per 12-ounce can and only 3.2 grams of carbohydrates.

This beer is made from quality ingredients and has a light and crisp taste. It is a great alternative to regular beer and is a popular choice for many people.

It is also a great option for those who are trying to lose weight as it is low in calories and carbs. It is also an easy drink to consume and can be enjoyed in moderation.

Another great thing about this beer is that it does not contain sugar. This is important to those who are trying to avoid sugar in their diet.

This beer is a favorite for many people because it is light, refreshing, and low in calories. It is also a great option for those on a diet as it is low in carbohydrates and contains no fat or cholesterol.

How Many Calories Are There In A 16 Oz Miller Lite

If you are looking for a delicious beer that does not have too many calories, Miller Lite is the perfect choice. It offers 96 calories and 3.2 grams of carbohydrates per 12 oz serving, making it a great choice for those who are trying to maintain a healthy diet.

However, it is still important to keep in mind that moderation is key when it comes to consuming alcohol. Drinking more than the recommended amount can lead to a number of health problems, including weight gain and increased blood pressure.

The average person can consume about three cans of Miller Lite in a single night and reach a BAC level of 0.064%, which is enough to get you drunk. The effects are usually noticeable by the third hour and last for about four hours.

While Miller Lite has fewer calories than its regular counterpart, it is still a popular choice amongst beer drinkers due to its light and refreshing taste. It is also an excellent option for those with dietary restrictions or health concerns, as it has no fat or cholesterol.

Xem thêm:

Frequently Asked Question

The name Miller Lite is often confused with its sister brand, Miller High Life. However, the two brands are different in many ways.

Miller Lite is an American light lager, meaning it is fermented in colder temperatures and uses bottom-fermenting yeasts. These characteristics make it an ideal brew for those who are looking to stay healthy, but still want to enjoy a great beer.

It is also lower in alcohol than most other beers. Its 4.2% ABV makes it suitable for those who enjoy a good drink, but don’t want to overindulge.

Aside from being low in alcohol, Miller Lite is also a refreshing brew with only 96 calories and 3.2 grams of carbs per serving. It is one of the best beers for those who are trying to keep their calorie intake in check, and it won gold at the 2016 World Beer Cup!

Since its introduction in the 1970s, Miller Lite has been one of the most popular beers in the United States. In fact, it is the original light beer in the country.

Conclusion

If you’re looking for a healthy and calorie-free beer that you can enjoy at any time, then Miller Lite is the perfect choice. It is a low-calorie beer that is full of vitamins and minerals, including Vitamin B6, Vitamin C, Vitamin E, Phosphorus, Calcium, Potassium, Zinc, and Selenium.

As far as the taste goes, Miller Lite has a light, medium-body malty brew scent with the hops aroma. This beer is usually brewed with Saaz and Galena hops that give it its complex flavor.

It is also a good source of Vitamin B12, Vitamin D, potassium, phosphorus, and zinc. Drinking this beer will boost your daily intake of vitamins and minerals, which can help keep you healthy.

Miller Lite is an American light lager with a low calorie content and a low alcohol content. It is a popular choice for those looking for a low-calorie, low carbohydrate beer.

[stonerbunnygirl420]

Got some goverment weed since all the shops here are basically closed for it. It was my first time ording and it came quick and easy. Got two brands I had before and im very happy with what i got!! Im having some beers and taking bowl hits on my bong. Makes life seem less shitty... time for another black and white film.

[cannaprocure]

Cannabis Beverages are a Fast Growing Segment

Cannabis companies are starting to bet big on the untapped potential of the beverage sector. As more people begin to move away from smoking cannabis, we have seen tremendous growth in the industry’s edibles, oils, and lotion sectors. Consumers want to enjoy their cannabis product without the harmful effect of smoke inhalation. 

The beverage industry, which includes soft drinks, juice, coffee, bottled water, energy drinks, and others, is globally valued at around $1.5 trillion and $150 billion in the U.S. alone. Beverage companies are always looking to find the next major growth opportunity in their industry.

Several small and larger beverage makers have caught the attention of the major players in the beverage industry. These beverage entrepreneurs are experimenting with cannabis-infused beverages and test marketing them in several markets. 

The cannabis industry is booming, and the beverage world isn't exactly sure how to get in on the action. A few big names have jumped on board with this new trend, like Molson-Coors, which released their line of cannabis-infused beverages in Canada; PepsiCo created a hemp-infused energy drink, and Canopy Growth introduced a top selling CBD beverage. Jones Soda also announced the launch of a line of cannabis-infused sodas under the name Mary Jones. These are just a few prominent beverage industry names adding cannabis-infused, hemp-infused, or CBD-infused beverages to their product line. 

Cannabis infusions and alcoholic beverages go hand-in-hand. Some companies are pairing the two types of products together for an even more enjoyable experience! For instance, you can enjoy cocktails at certain establishments that have been infused with marijuana. Several states are planning to launch such adult-use markets, and other states are contemplating venues such as lounges and bars that can make such alcohol and cannabis-based drinks. 

Companies are betting that consumers will be more open to cannabis beverages as an alternative to alcohol consumption, which has various drawbacks.  Cannabis is becoming more popular with health-conscious consumers who avoid smoking and looking for alternative products that won't affect them the next day. 

It is like this analogy:  Cannabis beverages are to high-THC products, as beer and spiked seltzer beverages are to high-proof alcohol such as vodka, gin, and tequila.

The lower alcohol content of beer and spiked seltzer makes those drinks more appealing to more people in more situations.  By the same token cannabis-infused drinks can reach a broader consumer base than traditional cannabis products.

However, for cannabis-infused beverages to meet overall consumer acceptance and reach their growth potential, several things need to happen, according to industry experts.

State labeling, testing, and packaging requirements need to be cohesive for cannabis beverages to scale. The need for separate regulations makes sense because these drinks are often mistakenly grouped in with edibles when they have different needs and/or characteristics. Lastly, on-site consumption, like in bars and restaurants, is critical to mainstreaming cannabis beverages.

The federal government has yet to legalize cannabis, so companies are hesitant about entering the industry. Alcohol brands have been quicker than others because it's not illegal in conjunction with beverages like water or coffee drinks that don't contain any alcohol.

The cannabis industry is a hotbed for regulation. The federal government has been strict about who can produce and sell what. Still, state laws vary significantly from one state to the next, which creates an uneven playing field in advertising, packaging, labeling, and even dosing instructions. 

The end of federal prohibition will bring about a new era for infused cannabis beverages. The cannabis industry and regulators will need to prioritize policies and reconcile the regulatory conditions and state-by-state differences. We’re also likely to see the industry come together and advocate for responsible consumption, standard procedures, and best practices.

The federal cannabis prohibition is attracting companies that produce CBD-only drinks. Sales of these products are expected to hit $2.5 billion in 2021, and they're available where cannabis isn't legal.

You may have heard of cannabis-infused beverages sold in Canada, but you will soon be able to enjoy them across the United States. The market for these drinks is predicted to grow by leaps and bounds over the next few years - so don't be surprised if someday you find one on your local grocery store shelf.

[vagabondretired]

By the Numbers:

Days 'til the midterm elections: 129 Days 'til the Hopkins Raspberry Festival in Minnesota: 7 Amount Rep. Joe Crowley spent in his NY-14 district to win reelection: $1.09 million Amount the actual winner, Alexandria Ocasio-Cortez, spent: $127,000 Temperature rise in the Northern Barents Sea since 2000, making it the world’s “Arctic warming hotspot”: 2.7F Percent chance that Molson Coors Brewing is planning to seal a deal with Canadian marijuana dealers so it can produce cannabis-infused beers: 100% Percent chance that New Hampshire Democrats added a call for pot legalization to their party platform: 100%

[marketinformation]

CBD Beverages Market May Set Epic Growth Story with the 27.4%

CBD Beverages Market report is segmented on the basis of type, application, and regional& country level. Based upon type CBD Beverages market is classified as Food Grade CBD Beverages and Pharmaceutical Grade CBD Beverages. Based upon application, CBD Beverages market is classified into mass markets, storefront dispensaries, convenience stores, and online stores.

CBD Beverages Market is valued at USD 2.09 Million in 2018 and expected to reach USD 11.38 Million by 2025 with the 27.4% CAGR of over the forecast period.

You Can Download 200 Pages PDF Copy of CBD Beverages Market @ https://brandessenceresearch.com/requestSample/PostId/412?utm_source=Free&utm_medium=AR

Market Analysis of CBD Beverages-

CBD, the contraction for cannabidiol, is one of the non-psychoactive ingredients in cannabis, increasingly offers wide-ranging health benefits with few side effects and low risk of addiction. Tetrahydrocannabinol or THC is the main psychoactive component of the cannabis plant. CBD beverages include everything from non-alcoholic wine, water, kombucha to cold brew coffee. With the hydration needs it offers a variety of other delicious drinks, including kombucha and CBD beverages.

Recently, CBD drinks are increasing in both popularity and availability as cannabis products and marijuana has become legalized in states across the country.

The FDA recently approved a CBD-based medication called Epidiolex, which is an oral cannabidiol solution, to help patients who suffer from certain types of seizures. CBD to consumable products may make it easier for consumers to incorporate it into their lifestyles and gain these benefits.

Top CBD Beverages Key Players–

Global CBD Beverages market Report covers prominent players are like Alkaline Water Company, Canopy Growth Corporation, New Age Beverages Corporation, Tilray Inc, Coca-Cola, Heineken, American Premium Water, Phivida Holdings, Cannara Biotech Inc, Molson Coors Brewing, Aurora Cannabis, CannTrust Holdings, CBD Biotechnology Co. Ltd and others.  

Global CBD Beverages Market Research Report also provides the latest companies data and industry future trends, allowing you to identify the products and end users driving profits growth and productivity. The Market report lists the most important competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The report includes the forecasts, investigation and discussion of significant industry trends, market volume, market share estimates and profiles of the leading industry Players. Global CBD Beverages Industry Market Research Report is providing exclusive vital statistics, information, data, trends and competitive landscape details.

Get Full Report: https://brandessenceresearch.com/consumer-goods/cbd-beverages-market-size

Key Benefits for Market Reports –

Global     market report covers in depth historical and forecast analysis.

Global     market research report provides detail information about Market     Introduction, Market Summary, Global market Revenue (Revenue USD), Market     Drivers, Market Restraints, Market opportunities, Competitive Analysis,     Regional and Country Level.

Global     market report helps to identify opportunities in market place.

Global     market report covers extensive analysis of emerging trends and competitive     landscape.

Market Segmentation –

By Type:-

Food     Grade CBD Beverages

Pharmaceutical     Grade CBD Beverages

By Application:-

Mass     Markets

Storefront     Dispensaries

Convenience     Stores

Online     Stores

Contact Us:

Alan Ruffalo

Corporate Sales: +44-20380741

Email: sales@brandessenceresearch.com

Web: https://brandessenceresearch.com/

[ericvick]

New Mexico, Switzerland, Federal Legalization, Aphria, Organigram And More

In spite of some good news on the legalization front, cannabis stocks traded down this week, largely driven by lackluster earnings reports out of big Canadian companies.

On Monday, New Mexico became the latest state to legalize adult-use cannabis, after Gov. Michelle Lujan Grisham signed the Cannabis Regulation Act. Sales are expected to begin before April 2022.

Following a legalization wave led by New York and Virginia, this approval puts more than 43% of Americans living in legal cannabis jurisdictions, according to The Marijuana Policy Project.

Switzerland will officially launch a trial version of a legal recreational cannabis market on May 15. The Swiss Federal Office of Public Health noted that the trial aims to offer “a scientific basis for the future regulation of cannabis.”

This will make Switzerland the first country in Europe to allow a legal adult-use cannabis supply chain. The trial will include 5,000 registered participants, who have proven to the Federal Government they already have been consuming cannabis.

Senate Majority Leader Chuck Schumer (D-NY) plans to present a federal cannabis legalization bill soon.

“I am going to put this bill on the floor soon. It hasn’t been introduced yet,” Schumer said, explaining he has been working with Senator Cory Booker (D-NJ) and Senate Finance Committee Chairman Ron Wyden (D-OR) on the measure’s draft. “Once it is introduced, it will go on the floor.”

Benzinga Cannabis’ content is now available in Spanish on El Planteo.

Dara Khosrowshahi, CEO of Uber Technologies Inc. (NYSE: UBER) revealed the company is open to including cannabis deliveries once the plant is legal on the federal level.

“When the road is clear for cannabis, when federal laws come into play, we’re absolutely going to take a look at it,” Khosrowshahi said during a CNBC interview.

ETFs were all down. Over the five trading days of this week:

The ETFMG Alternative Harvest ETF (NYSE: MJ): lost 5.6%.

The AdvisorShares Pure Cannabis ETF (NYSE: YOLO): tumbled 6.6%.

The AdvisorShares Pure US Cannabis ETF (NYSE: MSOS): dropped 5.55%.

The Cannabis ETF (NYSE: THCX): slipped 9.5%.

The Amplify Seymour Cannabis ETF (NYSE: CNBS): dropped 7.7%.

The SPDR S&P 500 ETF Trust (NYSE: SPY) was up 1.31%.

Policy, Science And Data

Story continues

Illinois cannabis taxes exceeded liquor taxes in the first three months of 2021, according to the state Department of Revenue. It’s the first time the Prairie State generated more tax revenue from cannabis than alcohol.

Marijuana tax revenue amounted to $86,537,000 in the last quarter, versus $72,281,000 from alcohol sales.

Michigan recreational and medical marijuana sales amounted to $115.4 million in March, according to Headset. That’s twofold growth compared to the same period last year.

A bipartisan bill to legalize medical cannabis for military veterans was reintroduced in Congress on Thursday.

A new study conducted by Harvard Medical School and McLean Hospital in Boston suggested cannabis treatment can significantly help with chronic pain.

The study revealed that those who used medical cannabis daily for six months experienced notable advancements in their overall health status: less pain and anxiety, better sleep and mood.

Akerna Corp (NASDAQ: KERN) expects national cannabis retail sales to reach $95 million on 4/20, the unofficial marijuana holiday. That’s according to a new Flash Report out of the Denver-based company.

The report suggests that the five days ending April 20 are expected to yield $370 million in cannabis sales.

“The numbers just keep growing in all aspects of the cannabis industry. This week, New Mexico became the 18th state to legalize adult-use cannabis. In addition to that, we got data from Akerna that suggested this 420 holiday could see $370 in total gross sales. Consumers are expected to begin making purchases on Friday and dispensaries are gearing up for their biggest weekend of the year,” Debra Boarchardt, CEO of Green Market Report, told Benzinga.

Earnings Reports

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) posted financial results for the third quarter and nine months ended Feb. 28. The company generated CA$153.6 million ($122.5 million) in net third-quarter revenue. That’s a year-over-year increase of 6.4% and a sequential decline of 4.3%.

Net cannabis revenue amounted to CA$51.7 million, dropping by 7.8% year-over-year and 23.8% sequentially.

View more earnings on MJ

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) reported that gross revenue decreased by 29% year-over-year to roughly CA$19.3 million ($15.4 million) in the second quarter of fiscal 2021.

Net revenue also declined over the same period, from CA$23.2 million to CA$14.6 million, the Moncton, New Brunswick-based company said in a statement.

The second-quarter results were “challenged by industry dynamics, COVID-19 and staffing limitations at our facility,” CEO Greg Engel said in a statement.

urban-gro Inc (NASDAQ: UGRO) posted preliminary first quarter 2021 results. Revenue rose by 174% year-over-year to a record $11.8 million to $12.1 million, up from $4.3 million reported in the same quarter last year.

Find all the details on these and other earnings reports on Benzinga Cannabis’ Earnings Center.

Financings And M&A

Aphria confirmed Thursday it has satisfied one of the requirements for its merger with Tilray Inc. (NASDAQ: TLRY) after its shareholders approved the arrangement at a special meeting. The special resolution approving the arrangement had to be endorsed by a minimum of two-thirds (66.6%) of the votes cast at the meeting. The merger got a 99.38% approval rate.

The closing of the deal still awaits customary conditions, such as court authorization and the approval of Tilray stockholders.

Cresco Labs (CSE: CL) (OTCQX: CRLBF) has taken over Bluma Wellness Inc. (CSE: BWEL) (OTCQX: BMWLF) in an all-stock transaction valued at $213 million.

Connected International Inc., also known as Connected Cannabis, completed a $30 million capital raise led by current investors Navy Capital and One Tower Group, who welcomed new investors, such as Emerald Park Capital, an affiliate of Bryant Park Capital, and Presidio View Capital.

Jushi Holdings Inc. (CSE: JUSH) (OTC: JUSHF) acquired a 93,000 sq. ft. facility, operated by its subsidiary, Dalitso LLC, for around $22 million.

Leune announced a $5-million capital raise Thursday supported by celebrity investors like professional basketball player Carmelo Anthony, his wife and TV personality La La Anthony and sports agent Rich Paul, who’s known for representing LeBron James and Anthony Davis.

Good Hemp, Inc. (OTC: GHMP) bought Diamond Creek Group, a manufacturer of ionized high alkaline spring water, for an undisclosed price. The Cornelius, North Carolina-headquartered producer of hemp seed oil-infused beverages said the move is part of a strategic plan to broaden its consumer reach.

Zip Run confirmed Friday it has raised $2.3 million via a seed funding round led by Mollitiam Capital, a private equity fund launched by Ross Bevevino and Tyson Macdonald.

Other News

Truss Beverage Co., a joint venture between brewer Molson Coors Beverage Co. (NYSE: TAP) and HEXO Corp. (NYSE: HEXO)(TSX: HEXO), is launching a lineup of six new CBD and THC products.

The Mint Dispensary will mark 4/20 with a name change to Mint Cannabis.

“As we continue to increase access to high-quality cannabis, it’s fitting that our name changes to better reflect our vision for the future,” Eivan Shahara, CEO of Brightroot Inc., parent company of Mint Cannabis, told Benzinga.

Keef Brands is expanding eastward into three new states: Missouri, Ohio and Maine.

Topical BioMedics announced an exclusive partnership and pharmacy distribution deal with Aspen, CO born Toast, a national cannabis and hemp company, making its line of topical, homeopathic pain relief creams available in more than 40,000 locations nationwide.

High Herstory, a new historical comedy series at the intersection of cannabis and feminism, is premiering on 4/20 to over 150 million homes through Social Club TV. Each episode showcases a female-identifying, cannabis-consuming storyteller, taking the audience along an action-packed journey through time.

Annette Mia Flores, co-founder of High Herstory, told Benzinga, “We are so proud to bring High Herstory to homes throughout the world. We’re putting a comedic edge on the painful underrepresentation women have faced throughout history, while smashing cannabis stigma at the same time. High Herstory Season 2 will spotlight women within the cannabis industry, from activists, to brands, scientists, and beyond. This is herstory in the making.”

Columbia Care Inc. (NEO:CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE:3LP) is launching a solid-fill cannabis powder capsule for medicinal use under the Ceed trademark in the United Kingdom.

The New York-based company opted to expand its product offering with the first solid-fill capsule of its kind in the U.K. In addition, it’s the first dose-metered medicinal cannabis product to be produced in the country.

Executive Moves

Find out all about the latest executive moves at:

TILT, BRNT, ECGI, Alcanna, WeedMD, Mind Cure, The FLowr Corporation, VIVO, Cannabiz, Team Hytiva

CanaQuest, Terra Tech, BioSteel, Halo Collective, Rolling Stone Culture Council, Australis

FastForward Innovations

Top Stories Of The Week

Check out the top stories on Benzinga Cannabis this week:

CBD-Infused Yerba Mate Maker Milonga To Launch K-Cups, Nespresso Pods

New Cannabis Products: Jay-Z’s Handrolled Joints, Papa & Barkley x El Blunto Cannagars, Live Resin Infused Pre-Rolls

Chelsea Handler On Cannabis, Her New HBO Max Special, Therapy And Psychedelics: ‘I’m Very Pro Drugs’

If You Invested ,000 In Canopy Growth Stock One Year Ago, Here’s How Much You’d Have Now

If You Invested ,000 In Aurora Cannabis Stock One Year Ago, Here’s How Much You’d Have Now

If You Invested ,000 In Tilray Stock One Year Ago, Here’s How Much You’d Have Now

If You Invested ,000 In Aphria Stock One Year Ago, Here’s How Much You’d Have Now

Video: KushCo CEO Explains How Greenlane Merger Catapults Them To ‘The Next Level’

Benzinga Cannabis Hour: MassRoots CEO, Dosist CMO Discuss Social Media In Cannabis

Top Spanish stories:

Lead image by Ilona Szentivanyi. Copyright: Benzinga.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[myrocketpaxdc]

Market sends Pepsi a message: Get on board with cannabis

Investors wanted PepsiCo Inc. to say yes to cannabis. Shares of the food and beverage giant were little changed in early trading on Tuesday after the company released quarterly earnings. But they took a dip after Chief Financial Officer Hugh Johnston said the company has no plans to invest in cannabis. Johnston was responding to a question from an analyst on the company’s earnings conference call. He said the federal ban on marijuana in the U.S. made it difficult for the maker of Mountain Dew and Cheetos to invest in the burgeoning industry. “It’s fair to say we look at everything, but certainly no plans at this point to do anything,” Johnston said. The stock was down 1.8 percent to $108.72 as of the close of the markets Tuesday in New York. The pending legislation of marijuana in Canada and the continued creep of loosening regulations in U.S. states have driven an investment boom, with valuations of pot companies soaring in recent weeks. The food and beverage industry, meanwhile, is pondering how a buzzy new ingredient could work in its products. Large beverage and alcohol companies, including Molson Coors Brewing Co. and Constellation Brands Inc., have invested in cannabis, while Coca-Cola Co. recently said it was examining the potential use of CBD, a non-psychoactive component of cannabis, for use in wellness drinks. thecannifornian.com Read the full article

[swanandcmiprs]

CANNABIS BEVERAGE MARKET ANALYSIS (2019-2027)

Cannabis Beverage Market – Insights

Cannabis beverages includes different types of alcoholic and non-alcoholic beverages which are infused with cannabis or marijuana. Rising concerns regarding hangovers and calorie-intake among consumers has encouraged companies operating in the food & beverages industry to invest in production of cannabis infused drinks.

The global cannabis beverage market was valued at US$ 205 million in 2018, and is expected to exhibit a CAGR of 38.3% over the forecast period (2019-2027), to reach US$ 2743.7 million by 2027.

Shifting preference of consumers towards cannabis from alcohol for recreational purposes is expected to drive the growth of the global cannabis beverage market in the next few years. The trends in consumption rate of alcohol and cannabis are diverging substantially in recent times. Growing consumer awareness regarding the hazardous effects of alcohol on human health has led to decrease in alcohol consumption among consumers. According to the U.S. National Survey on Drug Use and Health, 2.4 million people in U.S., over the age of 12, started using marijuana in 2013, which is around 6,600 new users on an average in a day.

On the basis of region, North America dominates the global cannabis beverage market with a significant share in 2018 in terms of revenue.  In 2018, the U.S. legalized cultivation of hemp, which is obtained from the cannabis plant but contains lesser tetrahydrocannabinol (THC) content, by implementation of the 2018 Farm bill. This bill allowed broad cultivation of hemp and removed the restrictions on sale, transportation and possession of products which are derived from hemp. This is expected encourage companies to launch new products in the region.

Figure 1. Global Cannabis Beverage Market Share (%), Analysis, By Distribution Channel, 2018

Furthermore, the increasing number of collaborations among leading companies with the goal of launching cannabis beverages is expected to fuel the growth of global cannabis beverages market. For instance, Hexo Corp., a Canada-based producer of cannabis products, formed a joint venture with Molson Coors Brewing Co., a producer of non-alcoholic beverages. In addition to this, in January 2020, Imaginary, a U.S.-based venture capital firm, invested US$ 5.0 million in Cann, an American company engaged in production and distribution of cannabis infused beverages.

Increasing recognition of cannabis for its medicinal and therapeutic benefits among consumers around the globe is likely to promote the growth of the global cannabis beverages market. Cannabis is used a medicinal drug owing to various health benefits that it provides such as blood pressure control, improvement in sleeping patterns, and relief from anxiety and depression. Extensive research has been done by pharmaceutical companies to produce cannabis-based medicines and treatments which are safe for health and do not cause any harmful side effects to the patients.

The cannabis extracts which are infused in beverages are mainly fat soluble i.e. they cannot dissolve in water. The key challenge for beverage manufacturers is to achieve proper mixing of cannabis extracts into the liquid and maintain the shelf-stability of the products. However, the fat-soluble nature of cannabis extracts means that its psychoactive effects are delayed and consumers end up consuming excessive quantities.

Figure 2. Global Cannabis Beverage Market – Opportunity Analysis

Key players operating in the global cannabis beverages market are focusing on launching new cannabis infused beverage products. For instance, in 2018, Lagunitas Brewing Company, a subsidiary of Heineken International involved in production of craft beers, launched its new range of cannabis infused beverages named Hi-Fi Hops. Furthermore, Top Beverages, a craft distiller of spirits and alcohol, launched a range of cannabis-based alcoholic beverages in November 2019. This scenario is projected to drive the market growth in coming years.

Major players operating in the global cannabis beverage market include MedReleaf Corp., Cronos Group Inc., GW Pharmaceuticals, Plc., CannTrust Holdings Inc., VIVO Cannabis Inc., Tilray Inc., General Cannabis Corporation, Koios Beverage Corporation, New Age Beverages Corporation, Dutch Windmill Spirits, Heineken, The Supreme Cannabis Company, and SK Rodnik.

Get free sample report here:   https://www.coherentmarketinsights.com/insight/request-sample/3390

Download PDF brochure:   https://www.coherentmarketinsights.com/insight/request-pdf/3390

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

•      Customized Market Research Services

•      Industry Analysis Services

•      Business Consulting Services

•      Market Intelligence Services

•      Long term Engagement Model

•      Country Specific Analysis

  Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: sales@coherentmarketinsights.com

  Source: https://www.coherentmarketinsights.com/market-insight/cannabis-beverage-market-3390

[janepwilliams87]

Hexo, Molson Coors launch Truss cannabis beverage portfolio

Canadian cannabis producer Hexo Corp. and brewer Molson Coors Canada have launched new beverage products under their Truss Beverage Co. joint venture, marking increased competition in Canada’s much-hyped marijuana beverage market. The lineup of five drink brands unveiled Tuesday includes both CBD and THC products. Most contain 2.5 milligrams to 5 milligrams of THC, characterized […]

Hexo, Molson Coors launch Truss cannabis beverage portfolio is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

from Updates By Jane https://mjbizdaily.com/hexo-molson-coors-launch-truss-cannabis-beverage-portfolio/

[itswallstreetpr]

The Cannabis Beverage Thesis (APHA, CVSI, MCTC, HEXO)

As the cannabis, hemp, and CBD space starts to heat back up, traders and investors are looking for emerging trends that could represent the new spark that lights the fire again among the larger retail investment public. One distinct possibility in that narrative is the cannabis-infused beverage space. A recent report by Grand View Research said that the global cannabis beverages market size is expected to reach $2.8 Billion by 2025 at a CAGR of 17.8%. According to the report, "By component, the market is segmented into Cannabidiol (CBD) and Tetrahydrocannabinol (THC). The demand of THC infused cannabis beverages is majorly driven by rising product demand from adult consumers for recreational purposes. Rising demand for the therapeutic effects of the component along with the euphoria it provides is expected to bode well for the growth of the segment in the forthcoming years." Active companies in the cannabis-infused beverage market include: Aphria Inc. (NYSE:APHA) (TSX:APHA), CV Sciences, Inc. (OTCQB:CVSI), Cannabis Global, Inc. (OTCMKTS:MCTC), and Hexo Corp (NYSE:HEXO) (TSX:HEXO).   Aphria Inc (NYSE:APHA) produces, supplies, and sells medical cannabis in Canada. Its cannabis products include dried flowers and cannabis oils. APHA sells its products through its online store and telephone orders, as well as MMPR licensed producers. APHA is also becoming a leader in the emerging cannabis beverages market. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders. The company sells its products through its online store or phones, as well as engages in the wholesale shipping of medical marijuana plant cuttings and dried buds to other licensed producers. Aphria Inc. is headquartered in Leamington, Canada. Shares acting well over the past five days, up about 18% in that timeframe. Aphria Inc (NYSE:APHA) managed to rope in revenues totaling $144.4M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 96.3%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($515.1M against $178.1M).   CV Sciences Inc (OTCMKTS:CVSI) bills itself as a company that operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. CV Sciences, Inc. has primary offices and facilities in San Diego, California and Las Vegas, Nevada. Moreover, CV Sciences, Inc. operates as a life science company. It operates through two segments, Specialty Pharmaceuticals and Consumer Products. The company focuses on developing and commercializing prescription drugs utilizing synthetic cannabidiol (CBD) as the active pharmaceutical ingredient. Its initial drug candidate is CVSI-007 that combines CBD and nicotine for the treatment of smokeless tobacco use and addiction. The company also engages in the development, manufacture, marketing, and sale of consumer products containing plant-based CBD under the PlusCBD Oil name in various market sectors, including nutraceutical, beauty care, specialty foods, and vape. Shares of the stock have powered higher over the past month, rallying roughly 65% in that time on strong overall action. CV Sciences Inc (OTCMKTS:CVSI) pulled in sales of $8.3M in its last reported quarterly financials, representing top line growth of -44.5%. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($7.6M against $12.5M, respectively).   MCTC Holdings Inc (OTCMKTS:MCTC), now doing business as Cannabis Global, Inc. (MCTC), is a more speculative play in the space, but recently put out news that suggests it has the potential to make big waves in the cannabis-infused beverage marketplace. Specifically, the company just announced it has completed product development and has begun distribution of its unique tetrahydrocannabivarin (THC-V) coffee and tea products to product beta testers. According to the release, “Cannabis Global has integrated three internally developed technologies into the unique manufacturing process for the industry's first THC-V beverages. The first of these is the process developed by the Company to produce 70%+ loaded THC-V, controlled release, nanoparticles utilizing laboratory-based, pharmaceutical-grade production equipment. The Company is also utilizing both its internally developed powerization and one step dosing system, ensuring precise dosing and significantly faster production. The Company has filed provisional patents on all three technologies.” Cannabis Global (OTCMKTS:MCTC) has recently filed six patents on cannabinoid extraction technologies and delivery systems. Management is currently working with patent counsel to protect various other technologies it has developed or is currently developing, including its programs pertaining to cannabinoid glycosides, polymeric cannabinoid nanoparticles and nanofibers, and its hemp extract-based alcohol replacement technologies. "Our unique infusion and production technologies provide Cannabis Global with a product purity advantage as well as a clear path to low cost leadership," commented CEO Arman Tabatabaei. "The THC-V cannabinoids are synthesized and entirely free of impurities. While there were some upfront technology development and intellectual property protection costs, we expect our ongoing variable production costs to be less than half of any potential competitor. Via our technologies, we turn one of the cannabis industry's most expensive items – pure THC-V cannabinoids – into a cost-effective solution that sets a new standard for product purity in the cannabinoid-based products marketplace." MCTC Holdings Inc (OTCMKTS:MCTC) had no reported sales in its last quarterly financial data. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($157K against $1.5M, respectively).   Hexo Corp (NYSE:HEXO) trumpets itself as a company that, through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company is also partnered up with Molson Coors (TAP) to make a big splash in the cannabis-infused beverage space. The company offers its adult-use and medical products under the HEXO brand name. HEXO Corp. is headquartered in Gatineau, Canada. The context for this stock is a bit of a bid, with shares acting well over the past five days, up about 28% in that timeframe. Shares of the stock have powered higher over the past month, rallying roughly 28% in that time on strong overall action. Hexo Corp (NYSE:HEXO) managed to rope in revenues totaling $17M in overall sales during the company's most recently reported quarterly financial data -- a figure that represents a rate of top line growth of 26.6%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($105.7M against $68.2M). Read the full article

[goldira01]

In the space of less than two years, cannabis stocks have lost billions in market value. Many of the nascent industry’s top players have lost half their market value or more. Leading Canadian cannabis stock Canopy Growth has plunged by a whopping 63% over the last year. The largest industry ETF, the ETFMG Alternative Harvest ETF, has lost 62%.

Despite some improved results from marijuana cultivators, such as Aurora Cannabis, reporting significantly, there is further pain ahead for cannabis investors. While the budding global legal marijuana industry is here to stay, it won’t be exactly how industry pundits postulated it would be.

Cannabis stocks facing headwinds

The global cannabis industry is undergoing a massive rationalization. Similar to what occurred after the dotcom bubble burst in 2000, that will see many cannabis companies fall by the wayside; they’ll either be acquired by larger competitors or cease to be going concerns. It is those cannabis companies with weak balance sheets that are bleeding red ink that are the most vulnerable.

That vulnerability is being magnified by the coronavirus pandemic, which has forced the closure of many dispensaries. The pandemic is also making it even more difficult for marijuana companies to access capital in an industry starved of funding.

There are also signs that the global legal cannabis market is not as large as originally believed. Some analysts put the total market value at somewhere around US$40 billion by the end of 2023. The expansion of world demand for legal cannabis and derivative products is threatened by the reluctance of many jurisdictions to fully legalize its medical and recreational use.

This bodes poorly for the earnings of cannabis stocks, which is a bad omen for an industry struggling with profitability.

Will this cannabis stock survive?

The challenging operating environment that now exists saw cultivator HEXO (TSX:HEXO)(NYSE:HEXO) flag in its second-quarter 2020 results that it lacked the financial resources to remain a going concern. Consequently, HEXO was pounded by the market, losing a whopping 92% over the last year. There could very well be worse ahead for the cannabis cultivator.

For its fiscal second quarter 2020, HEXO reported a $298 million net loss, which was around 75 times greater than its $4 million net loss a year earlier. That was despite revenue from sales soaring 47% year over year to almost $24 million. The large loss can be blamed on significant impairment charges against HEXO’s intangible assets and goodwill, which totalled $218 million for the quarter.

A culmination of ongoing losses and concerns over liquidity saw HEXO management issues a statement warning that the business may not remain as a going concern, unless it could raise additional funds. HEXO flagged that it lacked enough capital to meet funding requirements for debt, operations, and working capital requirements.

Since those results, HEXO tapped the market for $46 million through a full subscribed equity offering. While that gives HEXO some breathing room, it hasn’t solved the underlying problems: a lack of profitability and high rate of cash burn. HEXO does find itself in the enviable position of having the backing of brewer Molson Coors, which will help to ensure its survival.

Foolish takeaway

Cannabis stocks aren’t for faint-hearted investors. The industry’s ongoing problems, mostly related to a distinct lack of profitability, means there is a reckoning ahead for many marijuana cultivators. For these reasons, it is best to avoid Canadian cannabis stocks.

Looking for bargain stocks that could deliver outsized returns?

Just Released! 5 Stocks Under $49 (FREE REPORT)

Motley Fool Canada‘s market-beating team has just released a brand-new FREE report revealing 5 “dirt cheap” stocks that you can buy today for under $49 a share. Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune. Don’t miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.

Claim your FREE 5-stock report now!

Fool contributor Matt Smith has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

[superpraptithings]

The global cannabis market size is projected to reach USD 97.35 billion by the end of 2026. According to a report published by Fortune Business Insights™, titled “Cannabis Market Size, Share and Industry Analysis by Type (Flowers/Buds and Concentrates), By Application (Medical, Recreational (Edibles and Topical), and Industrial Hemp), and Regional Forecast 2019-2026”, the market size was USD 10.60 billion in 2018. The market will exhibit a CAGR of 32.92% during the forecast period, 2019-2026.

Cannabis is being legalized in several countries for medical and recreational purposes. The demand for cannabis has risen dramatically in the recent years due to the exceptional properties of the product, coupled with its medical benefits. The increasing therapeutic applications will create several opportunities for the companies operating in this market. The advent of cannabis-infused products such as edibles and drinks will aid the growth of the marijuana market in the coming years.

The high investments in the research and development of cannabis-infused drugs for several medical purposes will contribute to the Cannabis Market growth in the coming years. Furthermore, availability of the products in numerous variations will contribute to the growing demand and subsequent rise in the adoption of cannabis across diverse industrial applications.

List of best companies that are operating in the global cannabis market inlcude;

Aurora Cannabis

Aphria Inc.

Canopy Growth     Corporation

MedReleaf Corp.

Cronos Group     Inc.

GW     Pharmaceuticals, plc.

CannTrust     Holdings Inc.

VIVO Cannabis     Inc.

Tilray

OrganiGram     Holdings

The report encompasses several factors that have constituted the growth of the global market in recent years. It summarizes the key industry developments and gauges the impact of these developments on the market. It highlights key aspects of the market, with primary focus on leading products, major applications, and companies. The competitive landscape has been discussed in detail.

Additionally, the report provides forecast values for the medical Cannabis Market for the period of 2019-2026. Factual figures are obtained through trusted sources. The data provided in this report is gathered through opinions and interviews of world leaders and experienced market research professionals.

Increasing Investment in Product R&D to Aid Growth

The factors that have made a huge impact on the market have been discussed in the report. The benefits of cannabis have drawn the attention of several investors across the world. The increasing emphasis on the development of newer products, infused with cannabis will encourage several competitors to deviate from their core business and invest in medical cannabis. The legalization of cannabis in major countries across the world will emerge in favor of market growth.

In March 2019, Altria Group invested a whopping USD 1.8 billion in Cronos Group Inc. The company aims to compete, scale, and lead the global market and in doing so, establish a strong market presence. Such huge upfront investment will not only help the company but will also have a direct impact on the growth of the market in the coming years.

North America Dominates the Market; Legalization of Cannabis in Several States Will Open Up a Huge Potential

The market is segmented on the basis of regional demographics into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, the market in North America has emerged as the dominant region in recent years. Colorado and Washington DC were the first two states to legalize the use of recreational cannabis in the world. Several states have now legalized the use of recreational cannabis, as a result of which, the medical marijuana market will witness several market entrants in the coming years.

Key Industry Developments:

January 2019: The Colombian Medical Federation and Aphria announced a new alliance wherein they would develop a new academic curriculum on the medical benefits of recreational cannabis.

August 2018: Hexo Corp, announced a collaboration with Molson Coors Canada for the production of a new range of CBD-infused beverages.

To Gain More Insights into the Market with Detailed Table of Content and Figures, Click Here  https://www.fortunebusinessinsights.com/industry-reports/cannabis-marijuana-market-100219

[preciousmetals0]

The #1 Pot Stock to Buy During the Market Rally

The #1 Pot Stock to Buy During the Market Rally:

The market rally picked up steam in recent weeks, yet many pot stocks remain depressed — and for good reason. If you want to go bargain shopping for marijuana stocks, you need to be careful.

Today, some pot stocks are priced at ridiculous valuations. Fortunes are ready to be made. Other pot stocks, however, face a difficult future — one that potentially ends in bankruptcy.

Which pot stocks should you avoid during the market rally and which companies should you be buying? One cannabis producer sticks out: HEXO Corp (TSX:HEXO)(NYSE:HEXO).

Built for the long haul

We’ve learned a lot about the cannabis market since the bull run of 2018. That year, nearly every pot stock skyrocketed in value. Several companies garnered multi-billion dollar valuations during that market rally despite non-existent sales.

By 2019, those same stocks were plummeting. Most producers fell by 50% last year. Some lost more than 80%. Many investors were expecting a bounce-back in 2020, but the coronavirus pandemic squashed hopes for a rebound.

It’s been a rollercoaster, but here’s what we’ve learned.

First, cannabis producers need to be more than just cannabis producers. They need to become brands. Look at Coca-Cola. The beverage behemoth doesn’t make money by selling sugar and water, even though those ingredients constitute that majority of its products. Instead, the company profits by selling branded drinks.

Like sugar and water, cannabis is a commodity. If a company wants to avoid commoditization, it needs to figure out the branding equation.

The second lesson is that marijuana businesses must position themselves for the long run, not just for the next market rally. What exactly does that mean?

Look at Green Organic Dutchman Holdings. Last year it had a $1 billion valuation. Today it’s worth just $100 million. Sales are ramping, but the stock price is sinking. Investors don’t just demand sales growth these days, they want profits. Green Organic needs to raise money to survive, and in today’s market, fresh capital is no guarantee.

If you invest in the pot business, find a company that can outlast its financially vulnerable competition.

Buy this market rally

Given the lessons above, HEXO makes for a perfect buy amidst the market rally. But I’m not just talking about owning shares through the recent upturn. This stock should deliver gains for years to come.

When it comes to branding, HEXO is several steps ahead of the competition. The company has the second-highest number of patents in the industry, highlighting its differentiation. It was the first producer to launch a premium-branded line of products, labelled Original Stash. It also operates its own food laboratory and research facility with the goal of developing proprietary, value-add products.

Most promising is the company’s collaborations with existing brands. For example, this year HEXO is co-launching a THC-infused beverage with Molson Coors. The North American market for cannabis-infused beverages is expected to surpass $1.5 billion by 2026.

With a product ready for launch and a respected brand as a partner, HEXO is in the lead to take a large share of this nascent opportunity.

If you’re looking to buy high-growth stocks during the market rally, HEXO should top your list. Just be aware that this isn’t a short-term pick.

HEXO’s business model is built for the next decade of cannabis demand growth. Its early lead and financial stability make it an ideal long-term bet.

The Motley Fool recommends HEXO. and HEXO.

Fool contributor Ryan Vanzo has no position in any stocks mentioned.

[un-enfant-immature]

The budding industry of cannabis tech

Brian Kateman Contributor

Share on Twitter

Brian Kateman is president and co-founder of the Reducetarian Foundation.

More posts by this contributor

Fish replacement may be the next big wave in alternative protein development

From food and drink to health and wellness and beyond, there’s one plant we can’t seem to get enough of: cannabis. It seems like every consumer product nowadays is taking part in reefer madness.

Home cooks are taking edibles to new heights. In places like Denver and California, you can take cooking classes specifically centered around food made with Mary Jane. The editors of Vice’s “Munchies” even put out a cookbook last year called Bong Appétit: Mastering the Art of Cooking with Weed. And it’s only one of many.

But marijuana culture today isn’t all based around the stuff you (er, people you know) smoked in college. Cannabis, long known for its medicinal and therapeutic purposes, is a hot commodity in food tech and other consumer products nowadays. Far more than just a way to get high, cannabis in its various forms has been used medically throughout history and in modern times as a treatment for pain and nausea, and has been found anecdotally or in limited studies to treat glaucoma, epilepsy and anxiety, among other conditions and symptoms. Businesses have caught on, and not a moment too soon.

The food products that utilize marijuana are a far cry from the old classic pot brownies (not that there’s anything wrong with those!). Thanks to modern science, producers are able to separate the two main chemical compounds found in marijuana: THC and CBD. THC has therapeutic benefits, but it’s best known as the part of weed that gets you high. This is because it’s a psychoactive compound. CBD, on the other hand, is not psychoactive — it can (supposedly) provide many of the anti-anxiety, analgesic benefits of the plant without producing a high. For obvious reasons, this gives marijuana a new appeal. It’s now possible to reap the benefits of the plant without experiencing intoxication, so you can lessen anxiety or pain while still functioning normally.

It’s worth noting at this point that many of the health benefits of CBD and cannabis in general are not scientifically proven in statistically significant, peer-reviewed studies. This is for a number of reasons, most significantly that marijuana is still a Schedule 1 controlled substance under federal law in the U.S., making legality an issue in its study.

Clearly, the lack of scientific evidence isn’t diminishing anyone’s desire for herbal refreshment.

But what CBD and other cannabis products lack in evidence, they make up for with enthusiasm. Companies and consumers alike are eager to try CBD in various products, from food to oils to skincare, in hopes of treating anxiety, sleeplessness and other woes. If you live in a place where CBD products are legal, you’ve probably seen them everywhere. Newsweek reported that CBD sales are estimated to grow 40-fold in the next four years, reaching a value of $23 billion. The big business of marijuana and CBD — California-based Arena Pharmaceuticals is the biggest publicly traded cannabis company in the world — is only growing.

You can already find CBD candies and oils at major national retail chains like CVS and Walgreens, and in states and municipalities where it’s legal, green connoisseurs can order CBD-infused lattes and cocktails. Even retailers like Sephora, Neiman Marcus and Barneys are selling curated displays of CBD-infused beauty and skincare products. The aforementioned Newsweek article reports that big names like Coca-Cola and Molson Coors Brewing are among the hordes of companies already working on their own CBD products. Clearly, the lack of scientific evidence isn’t diminishing anyone’s desire for herbal refreshment.

Except for the FDA, that is. The legality of marijuana and CBD is a confusing and often contradictory topic, and a hard one to keep track of because it’s changing all the time at the federal, state and municipal levels. But what can be ascertained is that because so much of the CBD industry is operating outside of any kind of government oversight, legally or otherwise, the quality of products can vary widely. This is something about which the FDA and independent doctors and pharmaceutical experts have raised concerns. Apart from companies making unfounded claims about the effects of their products, the actual ingredient makeup may be inconsistent, with some products containing less CBD than their labels claim. Little regulation and nascent standards of quality mean consumers might not always know what they’re getting.

But given the broad interest in CBD, that’s unlikely to remain the case forever. The FDA may have started cracking down on extralegal CBD product sales, but in the grand scheme of things, that only means that the agency recognizes the significance of the compound. CBD probably isn’t going away anytime soon, and among the food, drug, health and cosmetic industries, the race to do it best and biggest has already begun.